From Name

From Email

To Name

To Email

Message

Medical trial aims to identify those at risk of heart damage following cancer treatment

from Medical Xpress

Medical trial aims to identify those at risk of heart damage following cancer treatment Medical Xpress The Australian Cardio Oncology Registry (ACOR)/Bio-bank study, a national first and the largest of its kind in the world, is recruiting across 12 hospitals for all current or previously treated patients exposed to therapies which can damage heart tissue, like chemotherapy, radiotherapy and immunotherapy. Cancer survivors can be of any age, including children, adolescents and adults. READ MORE

more